GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biosyent Inc (OTCPK:BIOYF) » Definitions » Price-to-Tangible-Book

Biosyent (Biosyent) Price-to-Tangible-Book : 2.94 (As of Apr. 27, 2024)


View and export this data going back to . Start your Free Trial

What is Biosyent Price-to-Tangible-Book?

As of today (2024-04-27), Biosyent's share price is $6.28. Biosyent's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $2.13. Hence, Biosyent's Price to Tangible Book Ratio of today is 2.94.

The historical rank and industry rank for Biosyent's Price-to-Tangible-Book or its related term are showing as below:

BIOYF' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.63   Med: 4.24   Max: 20.6
Current: 2.98

During the past 13 years, Biosyent's highest Price to Tangible Book Ratio was 20.60. The lowest was 2.63. And the median was 4.24.

BIOYF's Price-to-Tangible-Book is ranked worse than
61.28% of 873 companies
in the Drug Manufacturers industry
Industry Median: 2.36 vs BIOYF: 2.98

A closely related ratio is called PB Ratio. As of today, Biosyent's share price is $6.28. Biosyent's Book Value per Sharefor the quarter that ended in Dec. 2023 was $2.21. Hence, Biosyent's P/B Ratio of today is 2.85.


Biosyent Price-to-Tangible-Book Historical Data

The historical data trend for Biosyent's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosyent Price-to-Tangible-Book Chart

Biosyent Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.32 3.97 3.44 2.66 3.26

Biosyent Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.66 2.86 2.74 2.83 3.26

Competitive Comparison of Biosyent's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Biosyent's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biosyent's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biosyent's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Biosyent's Price-to-Tangible-Book falls into.



Biosyent Price-to-Tangible-Book Calculation

Biosyent's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=6.28/2.134
=2.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Biosyent Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Biosyent's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Biosyent (Biosyent) Business Description

Traded in Other Exchanges
Address
2476 Argentia Road, Suite 402, Toronto, Mississauga, ON, CAN, L5N 6M1
Biosyent Inc is a Canada-based growth-oriented specialty pharmaceutical company. It has focused on in-licensing or acquiring originative pharmaceuticals and other healthcare products. Its product includes FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Repagyn, and Tibella.

Biosyent (Biosyent) Headlines

From GuruFocus

When Being Certain Isn't Enough

By Thomas Macpherson Thomas Macpherson 08-30-2019

BioSyent Announces Grant of Restricted Share Units

By GlobeNewswire GlobeNewswire 03-31-2023

BioSyent Announces Changes to Executive Management

By GlobeNewswire GlobeNewswire 09-10-2018

BioSyent Declares Second Quarter 2023 Dividend

By GlobeNewswire GlobeNewswire 05-25-2023

BioSyent Schedules Q2 and H1 2022 Earnings Release for August 23, 2022

By GlobeNewswire GlobeNewswire 08-17-2022

BioSyent to Present at The LD 500 Virtual Conference

By ACCESSWIRE ACCESSWIRE 08-25-2020

BioSyent Announces Approval of New Product

By GlobeNewswire GlobeNewswire 05-31-2023

BioSyent Announces Adoption of Restricted Share Unit Plan

By GlobeNewswire GlobeNewswire 03-06-2020